공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

혈액 투석 및 복막 투석 시장 : 종류, 투석 장소, 모달리티, 제품, 지역별 - 세계 기회 분석 및 업계 예측(2020-2027년)

Hemodialysis and Peritoneal Dialysis Market by Type, Dialysis Site, Modality, and Product : Opportunity Analysis and Industry Forecast, 2020-2027

리서치사 Allied Market Research
발행일 2020년 12월 상품 코드 991226
페이지 정보 영문 262 Pages
가격
US $ 4,197 ₩ 4,868,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 6,269 ₩ 7,272,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 7,050 ₩ 8,178,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,832 ₩ 11,406,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



혈액 투석 및 복막 투석 시장 : 종류, 투석 장소, 모달리티, 제품, 지역별 - 세계 기회 분석 및 업계 예측(2020-2027년) Hemodialysis and Peritoneal Dialysis Market by Type, Dialysis Site, Modality, and Product : Opportunity Analysis and Industry Forecast, 2020-2027
발행일 : 2020년 12월 페이지 정보 : 영문 262 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 혈액 투석 및 복막 투석 시장 규모는 예측기간 중 6.0%의 연평균 복합 성장률(CAGR)로 확대되어 2019년 156억 8,181만 달러에서 2027년에는 221억 6,486만 달러에 달할 것으로 예측됩니다. 신장 관련 질환이나 신장 이식에 관한 문제 발생률 급증, 비만/당뇨병/고혈압 등의 생활습관병이나 만성질환 유병률 상승 등의 요인이 시장 성장을 가속하고 있습니다. 한편, 감염증, 저혈압, 체액 과다, 액세스 포인트 출혈 등의 합병증 증가가 시장의 새로운 성장을 방해하고 있습니다.

세계의 혈액 투석(Hemodialysis Dialysis) 및 복막 투석(Peritoneal Dialysis) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 상환 시나리오, 가격 동향, 시장 규모 추이와 예측, 종류·사이트·모달리티·제품·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 혈액 투석(HD)/복막 투석(PD) 유병률과 발생률
  • 가격 분석
  • 상환 시나리오
  • 주요 기업 리스트

제4장 시장 분석과 예측 : 유형별

  • 혈액 투석(HD)
    • 시장 점유율 분석 : 국가별
    • 단기 카테터(Non-cuffed tunneled catheters)
    • 만성 카테터(Cuffed tunneled catheters)
    • Graft(AVG)
    • Fistula(AVF)
  • 복막 투석(PD)
    • 주요 동향과 성장 기회
    • 시장 규모와 예측
    • 시장 점유율 분석 : 국가별

제5장 시장 분석과 예측 : 투석 장소별

  • 병원
  • 클리닉/투석센터
  • 가정 투석
    • 주요 동향과 성장 기회
    • 시장 규모와 예측
    • 시장 점유율 분석 : 국가별

제6장 시장 분석과 예측 : 모달리티별

  • 기존 투석
  • 연속 투석(주간, 야간)
    • 주요 동향, 성장요인, 성장 기회
    • 시장 규모와 예측
    • 시장 점유율 분석 : 국가별

제7장 시장 분석과 예측 : 제품별

  • 기기
  • 소모품
    • 주요 동향, 성장요인, 성장 기회
    • 시장 규모와 예측
    • 시장 점유율 분석 : 국가별

제8장 시장 분석과 예측 : 지역/주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카/중동 및 아프리카
    • 주요 동향, 성장요인, 시장 기회
    • 시장 규모와 예측 : 유형별
    • 시장 규모와 예측 : 투석 장소별
    • 시장 규모와 예측 : 모달리티별
    • 시장 규모와 예측 : 제품별
    • 시장 규모와 예측 : 국가별

제9장 기업 개요

  • FRESENIUS SE AND CO. KGAA
  • ASAHI KASEI CORPORATION
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON AND COMPANY(C. R. BARD, INC.)
  • COOK GROUP
  • ANGIODYNAMICS INC.
  • MEDTRONIC PLC.
  • NIKKISO CO. LTD.
  • NIPRO CORPORATION
LSH 21.03.05

LIST OF TABLES

  • TABLE 01.SIDE EFFECTS OF DIALYSIS
  • TABLE 02.PREVALENCE AND INCIDENCE OF HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENT (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 03.PRICING ANALYSIS BY ACCESS TYPE: AVERAGE PRICING RANGE (USD)
  • TABLE 04.AVERAGE SURVIVAL TIME OF VASCULAR ACCESS PRODUCTS
  • TABLE 05.ACCESS FISTULA AND GRAFTS
  • TABLE 06.ACCESS CATHETERS
  • TABLE 07.LIST OF MAJOR COMPANIES DELIVERING DIALYSIS SERVICES
  • TABLE 08.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 09.GLOBAL HEMODIALYSIS PATIENTS, BY ACCESS TYPE (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 10.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.GLOBAL HEMODIALYSIS PATIENTS WITH SHORT TERM CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 12.GLOBAL HEMODIALYSIS PATIENTS WITH CHRONIC CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 13.GLOBAL HEMODIALYSIS PATIENTS WITH GRAFT ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 14.GLOBAL HEMODIALYSIS FISTULA MARKET, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 15.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 17.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 21.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 22.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 24.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 25.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 26.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 27.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 28.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 29.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 30.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 31.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 32.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 33.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 34.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 35.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 36.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 37.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 38.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 39.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 40.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 41.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 42.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 43.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 44.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 45.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 46.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 47.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 48.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 49.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 50.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 51.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 52.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 53.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 54.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 55.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 56.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 57.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 58.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 59.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 60.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 61.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 62.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 63.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 64.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 65.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 66.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 67.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 68.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 69.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 70.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 71.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 72.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 73.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 74.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 75.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 76.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 77.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 78.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 79.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 80.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 81.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 82.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 83.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 84.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 85.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 86.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 87.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 88.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 89.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 90.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 91.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 92.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 93.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 94.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 95.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 96.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 97.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 98.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 99.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 100.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 101.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 102.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 103.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 104.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 105.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 106.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 107.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 108.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 109.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 110.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 111.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 112.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 113.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 114.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 115.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 116.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 117.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 118.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 119.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 120.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 121.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 122.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 123.FRESENIUS: COMPANY SNAPSHOT
  • TABLE 124.FRESENIUS: OPERATING SEGMENTS
  • TABLE 125.FRESENIUS: PRODUCT PORTFOLIO
  • TABLE 126.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127.ASAHI KASEI: COMPANY SNAPSHOT
  • TABLE 128.ASAHI KASEI: OPERATING SEGMENTS
  • TABLE 129.ASAHI KASEI: PRODUCT PORTFOLIO
  • TABLE 130.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 131.B. BRAUN: OPERATING SEGMENTS
  • TABLE 132.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 133.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134.BAXTER: COMPANY SNAPSHOT
  • TABLE 135.BAXTER: OPERATING SEGMENTS
  • TABLE 136.BAXTER: PRODUCT PORTFOLIO
  • TABLE 137.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138.BD: COMPANY SNAPSHOT
  • TABLE 139.BD: OPERATING SEGMENTS
  • TABLE 140.BD: PRODUCT PORTFOLIO
  • TABLE 141.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142.COOK: COMPANY SNAPSHOT
  • TABLE 143.COOK: OPERATING SEGMENTS
  • TABLE 144.COOK: PRODUCT PORTFOLIO
  • TABLE 145.ANGIODYNAMICS: COMPANY SNAPSHOT
  • TABLE 146.ANGIODYNAMICS: PRODUCT SEGMENTS
  • TABLE 147.ANGIODYNAMICS: PRODUCT PORTFOLIO
  • TABLE 148.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 149.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 150.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 151.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152.NIKKISO: COMPANY SNAPSHOT
  • TABLE 153.NIKKISO: OPERATING SEGMENTS
  • TABLE 154.NIKKISO: PRODUCT PORTFOLIO
  • TABLE 155.NIPRO: COMPANY SNAPSHOT
  • TABLE 156.NIPRO: OPERATING SEGMENTS
  • TABLE 157.NIPRO: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.SEGMENTATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
  • FIGURE 06.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 10.HIGH COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2019
  • FIGURE 12.RESTRAINTS AND DRIVERS: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
  • FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
  • FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
  • FIGURE 16.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 25.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
  • FIGURE 26.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
  • FIGURE 27.FRESENIUS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 28.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 29.FRESENIUS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 30.ASAHI KASEI: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 31.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 32.ASAHI KASEI: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 33.B. BRAUN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 34.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 35.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 36.BAXTER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 37.BAXTER: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 38.BAXTER: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 39.BD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 40.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 41.BD: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 42.ANGIODYNAMICS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 43.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2019 (%)
  • FIGURE 44.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 45.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 46.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 47.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 48.NIKKISO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.NIKKISO: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.NIKKISO: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 51.NIPRO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 52.NIPRO: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 53.NIPRO: REVENUE SHARE, BY REGION, 2019 (%)

Title:
Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 2020-2027.

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys. The procedure is vital during the treatment of end-stage renal disease (ESRD) and chronic kidney disease (CKD). Dialysis can be performed in two ways, namely; hemodialysis and peritoneal dialysis. In hemodialysis (HD), a filter is used to remove the waste products and extra fluids from blood. The purified blood is then reintroduced into the patient's body. On the other hand, peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called peritoneum and a dialysis solution to clean and purify blood and reinstate it into the patient's body. Both hemodialysis and peritoneal dialysis work on a similar principle of purifying the blood and removing toxins from patient's body, when kidneys are unable to function normally.

The global hemodialysis and peritoneal dialysis market was valued at $15,681.81 million in 2019, and is projected to reach $22,164.86 million by 2027, registering a CAGR of 6.0%. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global hemodialysis and peritoneal dialysis market growth. Conversely, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are likely to obstruct growth of the market in the coming years.

Similarly, reimbursement policy concerns in emerging nations impedes growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.

The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. The home dialysis segment is further classified into home hemodialysis and home peritoneal dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Type

  • Hemodialysis
  • Short-term Catheter
  • Chronic Catheter
  • Graft
  • Fistula
  • Peritoneal Dialysis

By Dialysis Site

  • Hospitals
  • Clinics & Dialysis Centers
  • Home Dialysis
  • Home Hemodialysis
  • Home Peritoneal Dialysis

By Modality

  • Conventional
  • Daily (Day Time, Night Time)

By Product

  • Devices
  • Consumables

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • KEY MARKET PLAYERS
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Nipro Corporation
  • B Braun Melsungen Ag
  • Nikkiso Co., Ltd.
  • Becton, Dickinson And Company (C. R. Bard, Inc.)
  • Cook Group
  • Angiodynamics Inc.
  • Medtronic PLC
  • Asahi Kasei Corp.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits to the stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Surge in incidences of kidney diseases
      • 3.5.1.2.Issues associated with kidney transplants
      • 3.5.1.3.Rise in prevalence of lifestyle and chronic diseases
    • 3.5.2.Restraints
      • 3.5.2.1.Complications in dialysis treatment
      • 3.5.2.2.Reimbursement policy concerns in emerging nations
    • 3.5.3.Opportunities
      • 3.5.3.1.Shift in preference of patients for home hemodialysis
      • 3.5.3.2.Surge in market strategies by key players
  • 3.6.Prevalence and Incidence of HD and PD: Important demographics
  • 3.7.Pricing analysis
  • 3.8.Average survival time of vascular access products
  • 3.9.Reimbursement scenario for dialysis (per patient)
  • 3.10.List of major morbidities associated with hemodialysis access procedures
  • 3.11.List of major companies delivering dialysis services

CHAPTER 4:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Hemodialysis (HD)
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market share analysis, by country
    • 4.2.4.Short-term Catheter (Non-cuffed tunneled catheters)
    • 4.2.5.Chronic Catheter (Cuffed tunneled catheters)
    • 4.2.6.Graft (AVG)
    • 4.2.7.Fistula (AVF)
  • 4.3.Peritoneal dialysis (PD)
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market share analysis, by country

CHAPTER 5:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals
    • 5.2.1.Key market trends and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market share analysis, by country
  • 5.3.Clinics & dialysis centers
    • 5.3.1.Key market trends and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market share analysis, by country
  • 5.4.Home dialysis
    • 5.4.1.Key market trends and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market share analysis, by country
    • 5.4.4.Market share analysis, by type
      • 5.4.4.1. Home Hemodialysis
      • 5.4.4.1.1.Market size and forecast, by region
      • 5.4.4.1.2.Market share analysis, by country
      • 5.4.4.2. Home Peritoneal Dialysis
      • 5.4.4.2.1.Market size and forecast, by region
      • 5.4.4.2.2.Market share analysis, by country

CHAPTER 6:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Conventional dialysis
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast
    • 6.2.3.Market share analysis, by country
  • 6.3.Daily dialysis (Day time/ Night time)
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast
    • 6.3.3.Market share analysis, by country

CHAPTER 7:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Devices
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast
    • 7.2.3.Market share analysis, by country
  • 7.3.Consumables
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast
    • 7.3.3.Market share analysis, by country

CHAPTER 8:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.Market size and forecast, by country
    • 8.2.3.Market size and forecast, by type
    • 8.2.4.Market size and forecast, by dialysis site
    • 8.2.5.Market size and forecast, by modality
    • 8.2.6.Market size and forecast, by product
    • 8.2.7.U.S.
      • 8.2.7.1.Market size and forecast, by type
      • 8.2.7.2.Market size and forecast, by dialysis site
      • 8.2.7.3.Market size and forecast, by modality
      • 8.2.7.4.Market size and forecast, by product
    • 8.2.8.Canada
      • 8.2.8.1.Market size and forecast, by type
      • 8.2.8.2.Market size and forecast, by dialysis site
      • 8.2.8.3.Market size and forecast, by modality
      • 8.2.8.4.Market size and forecast, by product
    • 8.2.9.Mexico
      • 8.2.9.1.Market size and forecast, by type
      • 8.2.9.2.Market size and forecast, by dialysis site
      • 8.2.9.3.Market size and forecast, by modality
      • 8.2.9.4.Market size and forecast, by product
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Market size and forecast, by country
    • 8.3.3.Market size and forecast, by type
    • 8.3.4.Market size and forecast, by dialysis site
    • 8.3.5.Market size and forecast, by modality
    • 8.3.6.Market size and forecast, by product
    • 8.3.7.UK
      • 8.3.7.1.Market size and forecast, by type
      • 8.3.7.2.Market size and forecast, by dialysis site
      • 8.3.7.3.Market size and forecast, by modality
      • 8.3.7.4.Market size and forecast, by product
    • 8.3.8.France
      • 8.3.8.1.Market size and forecast, by type
      • 8.3.8.2.Market size and forecast, by dialysis site
      • 8.3.8.3.Market size and forecast, by modality
      • 8.3.8.4.Market size and forecast, by product
    • 8.3.9.Spain
      • 8.3.9.1.Market size and forecast, by type
      • 8.3.9.2.Market size and forecast, by dialysis site
      • 8.3.9.3.Market size and forecast, by modality
      • 8.3.9.4.Market size and forecast, by product
    • 8.3.10.Italy
      • 8.3.10.1.Market size and forecast, by type
      • 8.3.10.2.Market size and forecast, by dialysis site
      • 8.3.10.3.Market size and forecast, by modality
      • 8.3.10.4.Market size and forecast, by product
    • 8.3.11.Germany
      • 8.3.11.1.Market size and forecast, by type
      • 8.3.11.2.Market size and forecast, by dialysis site
      • 8.3.11.3.Market size and forecast, by modality
      • 8.3.11.4.Market size and forecast, by product
    • 8.3.12.Rest of Europe
      • 8.3.12.1.Market size and forecast, by type
      • 8.3.12.2.Market size and forecast, by dialysis site
      • 8.3.12.3.Market size and forecast, by modality
      • 8.3.12.4.Market size and forecast, by product
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Market size and forecast, by country
    • 8.4.3.Market size and forecast, by type
    • 8.4.4.Market size and forecast, by dialysis site
    • 8.4.5.Market size and forecast, by modality
    • 8.4.6.Market size and forecast, by product
    • 8.4.7.Japan
      • 8.4.7.1.Market size and forecast, by type
      • 8.4.7.2.Market size and forecast, by dialysis site
      • 8.4.7.3.Market size and forecast, by modality
      • 8.4.7.4.Market size and forecast, by product
    • 8.4.8.China
      • 8.4.8.1.Market size and forecast, by type
      • 8.4.8.2.Market size and forecast, by dialysis site
      • 8.4.8.3.Market size and forecast, by modality
      • 8.4.8.4.Market size and forecast, by product
    • 8.4.9.Australia
      • 8.4.9.1.Market size and forecast, by type
      • 8.4.9.2.Market size and forecast, by dialysis site
      • 8.4.9.3.Market size and forecast, by modality
      • 8.4.9.4.Market size and forecast, by product
    • 8.4.10.India
      • 8.4.10.1.Market size and forecast, by type
      • 8.4.10.2.Market size and forecast, by dialysis site
      • 8.4.10.3.Market size and forecast, by modality
      • 8.4.10.4.Market size and forecast, by product
    • 8.4.11.South Korea
      • 8.4.11.1.Market size and forecast, by type
      • 8.4.11.2.Market size and forecast, by dialysis site
      • 8.4.11.3.Market size and forecast, by modality
      • 8.4.11.4.Market size and forecast, by product
    • 8.4.12.Rest of Asia-Pacific
      • 8.4.12.1.Market size and forecast, by type
      • 8.4.12.2.Market size and forecast, by dialysis site
      • 8.4.12.3.Market size and forecast, by modality
      • 8.4.12.4.Market size and forecast, by product
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.Market size and forecast, by country
    • 8.5.3.Market size and forecast, by type
    • 8.5.4.Market size and forecast, by dialysis site
    • 8.5.5.Market size and forecast, by modality
    • 8.5.6.Market size and forecast, by product
    • 8.5.7.Brazil
      • 8.5.7.1.Market size and forecast, by type
      • 8.5.7.2.Market size and forecast, by dialysis site
      • 8.5.7.3.Market size and forecast, by modality
      • 8.5.7.4.Market size and forecast, by product
    • 8.5.8.Saudi Arabia
      • 8.5.8.1.Market size and forecast, by type
      • 8.5.8.2.Market size and forecast, by dialysis site
      • 8.5.8.3.Market size and forecast, by modality
      • 8.5.8.4.Market size and forecast, by product
    • 8.5.9.South Africa
      • 8.5.9.1.Market size and forecast, by type
      • 8.5.9.2.Market size and forecast, by dialysis site
      • 8.5.9.3.Market size and forecast, by modality
      • 8.5.9.4.Market size and forecast, by product
    • 8.5.10.Rest of LAMEA
      • 8.5.10.1.Market size and forecast, by type
      • 8.5.10.2.Market size and forecast, by dialysis site
      • 8.5.10.3.Market size and forecast, by modality
      • 8.5.10.4.Market size and forecast, by product

CHAPTER 9:COMPANY PROFILES

  • 9.1.FRESENIUS SE AND CO. KGAA
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
    • 9.1.6.Key strategic moves and developments
  • 9.2.ASAHI KASEI CORPORATION
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business performance
  • 9.3.B. BRAUN MELSUNGEN AG
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
    • 9.3.5.Business performance
    • 9.3.6.Key strategic moves and developments
  • 9.4.BAXTER INTERNATIONAL INC.
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
    • 9.4.6.Key strategic moves and developments
  • 9.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance
    • 9.5.6.Key strategic moves and developments
  • 9.6.COOK GROUP
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
  • 9.7.ANGIODYNAMICS INC.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
  • 9.8.MEDTRONIC PLC.
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
    • 9.8.6.Key strategic moves and developments
  • 9.9.NIKKISO CO. LTD.
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
    • 9.9.5.Business performance
  • 9.10.NIPRO CORPORATION
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance
Back to Top
전화 문의
F A Q